Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
OpenAI in talks with Samsung to power AI features, report says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
South Korean military plans to launch new division for future warfare
-
8
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
S. Korea not to attend Sado mine memorial: foreign ministry
Boryung Pharm signed US$73m contract with Norvartis affiliate
By 황유미Published : June 20, 2016 - 09:47
[DISCLOSURE] Boryung Pharm (003850) has signed a US$73 million contract with Sandoz AG, an affiliate of Norvartis Group, the company announced on June 20. This amounts to 21.28 percent of its recent revenue. The 10-year contract is for supplying goods to six Southeast Asian countries and exclusive licensing.
